Logo image of ALBPK.PA

BROADPEAK (ALBPK.PA) Stock Fundamental Analysis

Europe - EPA:ALBPK - FR001400AJZ7 - Common Stock

2.25 EUR
+0.08 (+3.69%)
Last: 10/29/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALBPK. ALBPK was compared to 26 industry peers in the Communications Equipment industry. ALBPK has a bad profitability rating. Also its financial health evaluation is rather negative. ALBPK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALBPK has reported negative net income.
In the past year ALBPK had a positive cash flow from operations.
In multiple years ALBPK reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALBPK reported negative operating cash flow in multiple years.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

With a Return On Assets value of -7.91%, ALBPK is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
The Return On Equity of ALBPK (-19.96%) is worse than 65.38% of its industry peers.
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

Looking at the Gross Margin, with a value of 100.47%, ALBPK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ALBPK's Gross Margin has improved in the last couple of years.
ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

More info and screens

3

2. Health

2.1 Basic Checks

ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALBPK remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ALBPK has an improved debt to assets ratio.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALBPK has an Altman-Z score of 0.93. This is a bad value and indicates that ALBPK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.93, ALBPK is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALBPK is 16.11, which is on the high side as it means it would take ALBPK, 16.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALBPK (16.11) is worse than 69.23% of its industry peers.
ALBPK has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, ALBPK is in line with its industry, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Altman-Z 0.93
ROIC/WACCN/A
WACC6.86%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALBPK has a Current Ratio of 1.29. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, ALBPK is doing worse than 73.08% of the companies in the same industry.
ALBPK has a Quick Ratio of 1.29. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.29, ALBPK is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

ALBPK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.09%.
The Revenue has been growing slightly by 0.87% in the past year.
ALBPK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.93% yearly.
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%

3.2 Future

The Earnings Per Share is expected to grow by 43.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALBPK will show a quite strong growth in Revenue. The Revenue will grow by 8.91% on average per year.
EPS Next Y75.81%
EPS Next 2Y45.91%
EPS Next 3Y43.18%
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y8.99%
Revenue Next 3Y8.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBPK. In the last year negative earnings were reported.
Also next year ALBPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

ALBPK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.43
EV/EBITDA N/A
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALBPK's earnings are expected to grow with 43.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.91%
EPS Next 3Y43.18%

More info and screens

0

5. Dividend

5.1 Amount

ALBPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROADPEAK

EPA:ALBPK (10/29/2025, 7:00:00 PM)

2.25

+0.08 (+3.69%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.88%
Inst Owner ChangeN/A
Ins Owners49.73%
Ins Owner ChangeN/A
Market Cap28.21M
Revenue(TTM)39.38M
Net Income(TTM)-4024000
Analysts86
Price Target3.37 (49.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-275%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF 41.43
P/OCF 2.77
P/B 1.4
P/tB 10.54
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.05
FCFY2.41%
OCF(TTM)0.81
OCFY36.15%
SpS3.14
BVpS1.61
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100.48%
FCFM 1.73%
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Debt/EBITDA N/A
Cap/Depr 175.48%
Cap/Sales 24.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 0.93
F-Score6
WACC6.86%
ROIC/WACCN/A
Cap/Depr(3y)283.73%
Cap/Depr(5y)362.99%
Cap/Sales(3y)24.24%
Cap/Sales(5y)18.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y75.81%
EPS Next 2Y45.91%
EPS Next 3Y43.18%
EPS Next 5YN/A
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%
Revenue Next Year11.68%
Revenue Next 2Y8.99%
Revenue Next 3Y8.91%
Revenue Next 5YN/A
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year171.06%
EBIT Next 3Y53.71%
EBIT Next 5YN/A
FCF growth 1Y104.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y371.81%
OCF growth 3Y167.99%
OCF growth 5YN/A

BROADPEAK / ALBPK.PA FAQ

What is the ChartMill fundamental rating of BROADPEAK (ALBPK.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALBPK.PA.


Can you provide the valuation status for BROADPEAK?

ChartMill assigns a valuation rating of 1 / 10 to BROADPEAK (ALBPK.PA). This can be considered as Overvalued.


Can you provide the profitability details for BROADPEAK?

BROADPEAK (ALBPK.PA) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for ALBPK stock?

The Earnings per Share (EPS) of BROADPEAK (ALBPK.PA) is expected to grow by 75.81% in the next year.